Formoterol Fumarate

potassium calcium-activated channel subfamily M regulatory beta subunit 2 ; Homo sapiens







190 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
151 7503401 Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol. 1995 Aug 1
152 7551366 Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. 1995 Oct 1
153 7597661 Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients. 1995 May 2
154 7648384 Pharmacology of long-acting beta-agonists. 1995 Aug 2
155 8808181 Evaluation of different doses of formoterol from a newly developed powder inhalation device in asthmatic patients. 1995 1
156 7828656 High affinity [3H]formoterol binding sites in lung: characterization and autoradiographic mapping. 1994 Sep 15 1
157 7907426 [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study]. 1994 1
158 7913292 Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. 1994 Jul 3
159 7914175 Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic. 1994 May 1
160 7914366 [Long-term effect of the beta 2-sympathomimetic formoterol in young smokers--study of duration and site of effect of bronchodilatation using conventional methods of lung function and monodispersed aerosols]. 1994 Apr 2
161 7939538 [Long-acting beta-2-agonists in the treatment of asthma]. 1994 Oct 1 1
162 8149969 Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. 1994 Jan 14 1
163 8095240 A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. 1993 Feb 1
164 8095250 The onset of action of formoterol, a new beta 2 adrenoceptor agonist. 1993 Jan 1
165 8095323 [A new beta-2 sympathomimetic drug with longer effectiveness. Comparison with current beta-2 sympathomimetic drugs in therapy of bronchial asthma in childhood]. 1993 Jan 1
166 8100394 Beta 2-agonists as anti-inflammatory therapies in the lung. 1993 1
167 8101796 In vitro effect of beta 2-agonists on bacterial killing and superoxide anion (O2-) release from alveolar macrophages of patients with chronic bronchitis. 1993 Aug 1
168 8346490 Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. 1993 Jun 1
169 1346963 Risks versus benefits of inhaled beta 2-agonists in the management of asthma. 1992 Jan-Feb 1
170 1348219 Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects. 1992 Apr 2
171 1348515 Late asthmatic reaction decreased after pretreatment with salbutamol and formoterol, a new long-acting beta 2-agonist. 1992 Apr 1
172 1360774 Sustained improvement in asthma with long-term use of formoterol fumarate. 1992 Nov 1
173 1363036 [Long-term tolerability of formoterol in chronic obstructive bronchopathies]. 1992 Nov 2
174 1424880 Formoterol suspension aerosol. Comparison with formoterol solution aerosol for 12 weeks in asthmatic patients. 1992 Nov 1
175 1443864 Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. 1992 Nov 1
176 1673830 Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol. 1991 May 2
177 1677894 Protective effect and duration of action of formoterol aerosol on exercise-induced asthma. 1991 Mar 1
178 1686531 Pharmacology of formoterol: an innovative bronchodilator. 1991 2
179 1718682 Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. 1991 Jul 2
180 1892303 A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. 1991 Sep 1
181 1972599 Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. 1990 Apr 2
182 1974680 Long-term studies on long-acting sympathomimetics. 1990 1
183 1974686 Long-term efficacy of formoterol compared to salbutamol. 1990 1
184 1974687 Multicenter 1-year trial on formoterol, a new long-acting beta 2-agonist, in chronic obstructive airway disease. 1990 1
185 1974689 Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma. 1990 1
186 1978619 Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. 1990 Nov 1
187 2236756 Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting beta 2-adrenergic agonist. 1990 Jul 1
188 2574732 Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. 1989 Dec 1
189 2797925 Formoterol and salbutamol metered aerosols: comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma. 1989 1
190 6138697 The development of a radioimmunoassay for formoterol. 1983 Oct 24 1